The young and ravishing bollywood actress Katrina laughed over the idle talk of he
The Indian stock markets collapsed with Sensex falling 769 points on fears that risin
Washington, Dec 18: New findings from NASA observatories indicate that a powerful jet from a super massivThe African iGaming market is entering a new era of innovation and competitiveness as two notable industry forces—Booming Games and Bitville Gaming—join hands to accelerate digital transformation a
News in Focus
In an era where digital leisure has eclipsed traditional modes of entertainment, the online betting ecosystem has surged ahead, blending innovation, accessibility, and regulatory adaptation.
Kotak Institutional Equities has issued a BUY recommendation on InterGlobe Aviation (IndiGo), underscoring the carrier’s strategic prowess in capacity planning, international expansion, and differe
Motilal Oswal Financial Services has issued a BUY recommendation on JK Cement, underlining the company’s robust operational execution and ambitious expansion agenda.
Kotak Institutional Equities has issued a BUY Call on Tata Consultancy Services (TCS), maintaining a fair value target of Rs3,800 per share.
IREDA share price will be in focus on Friday as the PSU energy development major has declared quarterly results.
Main Regional Stories
Maruti Suzuki, Tata Steel, Bajaj Finance, Jio Financial Services and Tata Motors were among major gainers on NSE Nifty on Thursday. Overall market trend was bearish and NSE Nifty 50 closed the session with 120 points loss.
Featured, Analyst View, CRISPR Therapeutics, Morningstar Research, Pharmaceutical Sector, Switzerland
Morningstar has issued a BUY recommendation on CRISPR Therapeutics AG (NASDAQ: CRSP), underscoring the stock’s significant undervaluation and robust long-term prospects, in its latest research report dated July 9, 2025.
IndusInd Bank, Bajaj Finserv and Jio Financial Services were among major gainers in today's session with IndusInd Bank trading 1.6 percent higher.
Motilal Oswal Securities has reiterated a BUY call on Lodha Developers, projecting a robust 36% upside with a revised target price of Rs 1,870 per share.
